Amanta Healthcare Ltd.

164.64

-3.4 (-2%)stock indicator image for downward trend

As on July 20, 2026
SectorNA
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap639 Cr
P/E Ratio45.2
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open168.84
High168.84
NSE SymbolAMANTA
Close164.64
Low164.64
BSE Symbol544502
Previous Years High/Low
1 Year High189
3 Year High189
5 Year High189
1 Year Low92
3 Year Low92
5 Year Low92

Technicals


IndicatorsValueSignal
5-DMA167.73Bearish
10-DMA174.25Bearish
20-DMA168.19Bearish
50-DMA148.51Bullish
100-DMA130.16Bullish
200-DMA122.18Bullish

Historical Performance


1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 45.2, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹611 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹2747 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 1161481.5
No. of Shares: 7055 (Approx)
Performance:16.1%
161481.5
NIFTY Performance: -3.4%
1 day Top Gainers
SymbolChange%
PNB111.76(6%)
METROPOLIS573.75(5%)
TORNTPHARM5005.4(5%)
JSWENERGY567.7(5%)
SCHNEIDER1341(5%)
1 Day Top Losers
SymbolChange%
MAPMYINDIA1097(-7%)
AXISBANK1256(-6%)
ECLERX1877.5(-5%)
HDFCBANK777.6(-5%)
RELINFRA63.19(-5%)
CAMPUS225.21(-5%)
INDIACEM392.5(-4%)
CEATLTD3407.3(-4%)

Top Performing Stocks from the same sector


Bafna Pharmaceuticals Ltd.

43%

229

1 Month Performance

Unichem Laboratories Ltd.

34.1%

595.6

1 Month Performance

RPG Life Sciences Ltd.

32.5%

3017.1

1 Month Performance

Wanbury Ltd.

27.4%

339.9

1 Month Performance

Ind-Swift Laboratories Ltd.

24.9%

233.99

1 Month Performance

Bajaj Healthcare Ltd.

23.5%

386.55

1 Month Performance

Beta Drugs Ltd.

22.6%

2439.4

1 Month Performance

Hester Biosciences Ltd.

21.5%

2523.4

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month